Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Head of German drug agency to leave post

Nature (2010)Cite this article

Subjects

Board calls time on embattled director of pharmaceutical evaluation institute.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hemkens, L. G. et al. Diabetologia 52, 1732-1744 (2009).

    Article  CAS  Google Scholar 

  2. Pocock, S. J. & Smeeth, L. Lancet 374, 511-513 (2009).

    Article  Google Scholar 

  3. Hemkens, L. G., Bender, R., Grouven, U. & Sawicki, P. T. Lancet 374, 1743-1744 (2009).

    Article  Google Scholar 

Download references

Authors
  1. Quirin Schiermeier
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related external links

Institute for Quality and Efficiency in Health Care

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schiermeier, Q. Head of German drug agency to leave post. Nature (2010). https://doi.org/10.1038/news.2010.34

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news.2010.34

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research